(BRK.A), (BRK.B)
Lubrizol, a Berkshire Hathaway company, has announced compelling clinical results for its CURCUSHINE™ microencapsulated curcumin ingredient, which showed significant improvements in skin radiance, wrinkle reduction, and overall skin appearance. The findings, published in Agro FOOD Industry hi-tech, confirm the efficacy of CURCUSHINE™ as a potent beauty-from-within nutraceutical ingredient.
In the study, 63 women aged 21 to 50 with self-reported skin imperfections consumed either CURCUSHINE™ microcapsules or a placebo daily for six weeks. Those taking CURCUSHINE™ experienced a:
19% increase in skin luminosity and up to 69% improvement in skin tone uniformity
8% reduction in dark spots
10.32% average reduction in crow’s feet wrinkle volume
5.14% average reduction in forehead wrinkle volume
Notable improvement in facial skin brightness (L* parameter)
These results build on previous in vitro research demonstrating CURCUSHINE™’s protective effects on collagen and elastin against oxidative and inflammatory stress.
“Aging gracefully is a growing concern among younger adults, including Gen Z and Millennials,” said Isabel Gómez, Global Marketing Manager for Lubrizol Nutraceuticals. “We’re proud to offer a clinically proven solution for skin rejuvenation with CURCUSHINE™.”
CURCUSHINE™ microcapsules are water-dispersible, taste-neutral, and highly bioavailable—making them ideal for a wide range of nutricosmetic formats, including tablets, capsules, gummies, powder sachets, and functional beverages.
© 2025 David Mazor
Disclosure: David Mazor is a freelance writer focusing on Berkshire Hathaway. The author is long in Berkshire Hathaway, and this article is not a recommendation on whether to buy or sell the stock. The information contained in this article should not be construed as personalized or individualized investment advice. Past performance is no guarantee of future results.